Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Movado Group
MOV
$815M
| $8.72M | ﹤0.01% |
276,919
+5,813
| +2% | +$186K |
|
2552
Rhythm Pharmaceuticals
RYTM
$8.1B
| $8.72M | ﹤0.01% |
667,658
-17,245
| -3% | -$263K |
|
|
ROVR
2553
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $8.71M | ﹤0.01% |
+641,059
| New | +$7.9M |
|
|
AMTI
2554
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $8.7M | ﹤0.01% |
336,490
-30,949
| -8% | -$981K |
|
2555
Hackett Group
HCKT
$278M
| $8.7M | ﹤0.01% |
443,425
-7,410
| -2% | -$139K |
|
2556
International Money Express
IMXI
$353M
| $8.69M | ﹤0.01% |
520,519
+11,601
| +2% | +$194K |
|
2557
Petrobras Class A
PBR.A
$104B
| $8.69M | ﹤0.01% |
868,651
+130
| +0% | +$1.34K |
|
2558
Xometry
XMTR
$5.34B
| $8.69M | ﹤0.01% |
150,632
+122,332
| +432% | +$8.48M |
|
|
EPZM
2559
DELISTED
Epizyme, Inc
EPZM
| $8.67M | ﹤0.01% |
1,693,517
+52,025
| +3% | +$316K |
|
|
CMRX
2560
DELISTED
Chimerix, Inc.
CMRX
| $8.65M | ﹤0.01% |
1,397,577
+9,936
| +0.7% | +$68.3K |
|
2561
Alerus Financial
ALRS
$843M
| $8.65M | ﹤0.01% |
289,492
+1,623
| +0.6% | +$46.7K |
|
2562
Amneal Pharmaceuticals
AMRX
$6.15B
| $8.65M | ﹤0.01% |
1,619,999
-262,711
| -14% | -$1.32M |
|
2563
SunCoke Energy
SXC
$788M
| $8.65M | ﹤0.01% |
1,377,500
+17,868
| +1% | +$123K |
|
2564
Outdoor Holding Co
POWW
$255M
| $8.65M | ﹤0.01% |
1,406,067
+210,259
| +18% | +$1.51M |
|
|
VIEW
2565
DELISTED
View, Inc. Class A Common Stock
VIEW
| $8.65M | ﹤0.01% |
26,592
+2,246
| +9% | +$789K |
|
2566
Verastem
VSTM
$604M
| $8.63M | ﹤0.01% |
233,617
+1,300
| +0.6% | +$47.8K |
|
|
GTHX
2567
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $8.63M | ﹤0.01% |
643,103
+32,779
| +5% | +$534K |
|
2568
First Community Bankshares
FCBC
$927M
| $8.63M | ﹤0.01% |
272,012
-683
| -0.3% | -$20.6K |
|
2569
Mercantile Bank Corp
MBWM
$1.06B
| $8.62M | ﹤0.01% |
269,216
-1,294
| -0.5% | -$40.1K |
|
|
QUOT
2570
DELISTED
Quotient Technology Inc
QUOT
| $8.62M | ﹤0.01% |
1,480,888
+104,052
| +8% | +$872K |
|
2571
Omega Flex
OFLX
$304M
| $8.61M | ﹤0.01% |
60,365
-82
| -0.1% | -$12.4K |
|
2572
Descartes Systems
DSGX
$6.62B
| $8.6M | ﹤0.01% |
104,751
+7,813
| +8% | +$592K |
|
2573
Inseego
INSG
$82.6M
| $8.58M | ﹤0.01% |
128,875
-11,156
| -8% | -$933K |
|
2574
Republic Bancorp
RBCAA
$1.91B
| $8.58M | ﹤0.01% |
169,465
-3,455
| -2% | -$169K |
|
2575
AerCap
AER
$23.6B
| $8.57M | ﹤0.01% |
148,252
+2,378
| +2% | +$127K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.